Phase 2 Case Study

phase 2 logoPhase 2 Case Study

Contract Manufacturer Expands Production Nearshore with New 30,000SF Facility

A conversation with Phase 2 Medical Manufacturing, featuring: Adam Prime, CEO and Ben Prime, Technical Manager OUS


Nearshore Total Landed Cost Shows Offshore is More Expensive

We found that buildings were readily available, and business and labor costs were better than in Costa Rica. We [also] ruled out China because it was not a good fit. Beyond the political situation and rising labor and shipping costs, it was too far away for us to manage.

Customers began telling Phase 2 that the availability of low-cost labor outside the United States would be a criteria for vendor sourcing going forward. Phase 2 ruled out China due to rising labor costs, rising shipping costs and being too far away to manage. Costa Rica was also ruled out, largely because of the 18 days time on the water to the United States. With North America generating the most revenue for the medical device industry in 2013, and the US representing 38% of the global sector, manufacturers have lost their infatuation with offshore manufacturing.


A Cost-Effective, Well-Established, and Mature Industry

The labor force appears to be abundant and capable. Being a finished goods contract manufacturer of medical devices, cost is a huge deal for us, as is proximity to the United States.

Just south of San Diego, California, Tijuana has an over 30-year history in medical device manufacturing and is highly regarded as a major global hub for medical device manufacturing. Boasting a 50,000 person-strong labor pool directly serving the 70 companies operating in the region, the medical device industry in Baja California represents the largest concentration of companies and of job creation in Mexico.

Mexico is also the fifth largest exporter of medical products in the world, with 50% of these exports coming out of Baja California.


How Nearshoring Creates New Supply Chain Opportunites

Our customers are looking for more vertical integration. The new nearshore plant and our new capabilities in medical injection molding are significant milestones in Phase 2's growing abilities to meet and even exceed our client’s expectations; while also attracting new customers seeking high-quality contract medical manufacturing.

With global medical device outsourcing forecasted to reach more than $50 billion by 2020, there are no shortages of new markets and new customers to tap into. Strategic positioning and location are now just as crucial as your marketing and sales force. With an average of 15% production cost savings for OEMS who outsource to CMOs, Phase 2’s expansion in Tijuana has placed them at the center of the industry. With the trending best practice of the “One Stop Shop,” medical device OEMs are now seeking contract manufacturers with a global footprint and an increased breadth of services and capabilities.


Working with CPI is the Most Cost-Effective Way to Expand

Phase 2 was set up in Tijuana in months, and the only way it was possible was through the efforts of CPI. CPI visited our plant in New Hampshire to get an excellent understanding of what we do, how we do it, the space we needed, and the level of expertise required by our labor force. These details allowed them to search the available real estate, as well as calibrate themselves on what style of employee Phase 2 requires.


co production logoWorking with an administrative and shelter service firm is the new best practice for expanding manufacturing operations outside of the United States.

Manufacturers gain a strategic and cost effective advantage working with companies like CPI who handle the entire process of exploration, analysis and complete set-up. Hiring in-house site or expansion teams just isn’t cost effective anymore, especially including the added cost and time spent navigating and complying with a foreign country’s business regulatory requirements.

CPI offers manufacturers a unique and innate advantage over an in-house team: the local knowledge, expertise and established network of partners.

Download PHASE2 Case Study document in PDF format.
Click to download

phase 2 tijuana facility mexico manufacturing

Phase 2 Medical Manufacturing is a medical device contract manufacturer of single-use, disposable medical devices offering turnkey medical manufacturing for products that require product development, cleanroom injection molding, cleanroom manufacturing, medical assembly, testing, medical packaging, shipping, and sterilization services. FDA registered and certified to ISO 13485 with ISO Class 8 clean rooms at global facilities at both New Hampshire and Tijuana facilities.

For more information

phase 2 tijuana facility mexico manufacturing clean room

phase 2 tijuana facility mexico manufacturing medical device

phase2 map medical device hub

over 35 years manufacturing experience

Over 35-years of Extensive Experience

CPI can virtually guarantee the successful establishment and ongoing administrative functions of your facility. CPI's services are designed to ensure your facility is operating at peak performance with minimal costs and full compliance to Mexican laws and regulations.

Learn more about Co-Production International Programs

mexico manufacturing logo cpi

ico flag usaUS Corporate Office
Phone: +1(619) 429-4344
8716 Sherwood Terrace
San Diego, CA 92154 USA

mexico icoMexico Corporate Office
Phone: +1(855) 480-0837
Blvd. Corredor Tijuana-Rosarito 2000
15202 Int. Mt8, Zona Cerril General
Tijuana, BC 22330, Mexico


Co-Production International Inc BBB Business Review

S5 Box